Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The ASPIRE-GCA Pilot trial will assess the feasibility of a future randomized controlled trial (RCT) evaluating the efficacy of low-dose ASA in preventing ischemic complications in patients with Giant Cell Arteritis (GCA). ASPIRE-GCA Pilot builds on extensive preparatory work and the findings from this study will inform key feasibility outcomes, including recruitment rate, study-drug delivery and treatment initiation, medication adherence, participant retention, and completeness of follow-up data.
Epistemonikos ID: e81f3389bd2a85a506520d781e27815981d44148
First added on: Oct 31, 2026